nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Platelet count decreased—Entecavir—hepatitis B	0.0297	0.0301	CcSEcCtD
Gemifloxacin—Serum creatinine increased—Entecavir—hepatitis B	0.0288	0.0291	CcSEcCtD
Gemifloxacin—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0281	0.0284	CcSEcCtD
Gemifloxacin—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.0276	0.028	CcSEcCtD
Gemifloxacin—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.0211	0.0214	CcSEcCtD
Gemifloxacin—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.0156	0.0158	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Entecavir—hepatitis B	0.012	0.0122	CcSEcCtD
Gemifloxacin—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.0119	0.012	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0117	0.0119	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0111	0.0112	CcSEcCtD
Gemifloxacin—Pancreatitis—Entecavir—hepatitis B	0.0109	0.011	CcSEcCtD
Gemifloxacin—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.0106	0.0107	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Entecavir—hepatitis B	0.01	0.0101	CcSEcCtD
Gemifloxacin—Renal failure—Entecavir—hepatitis B	0.00973	0.00984	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0095	0.00961	CcSEcCtD
Gemifloxacin—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00949	0.0096	CcSEcCtD
Gemifloxacin—Haematuria—Entecavir—hepatitis B	0.00944	0.00954	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Entecavir—hepatitis B	0.00936	0.00947	CcSEcCtD
Gemifloxacin—Gastritis—Telbivudine—hepatitis B	0.00934	0.00944	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0093	0.00941	CcSEcCtD
Gemifloxacin—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00921	0.00931	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00913	0.00923	CcSEcCtD
Gemifloxacin—Oedema peripheral—Entecavir—hepatitis B	0.00875	0.00885	CcSEcCtD
Gemifloxacin—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.0086	0.0087	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00856	0.00866	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00852	0.00861	CcSEcCtD
Gemifloxacin—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0085	0.00859	CcSEcCtD
Gemifloxacin—Eructation—Lamivudine—hepatitis B	0.00805	0.00814	CcSEcCtD
Gemifloxacin—Immune system disorder—Entecavir—hepatitis B	0.00802	0.00811	CcSEcCtD
Gemifloxacin—Renal failure—Telbivudine—hepatitis B	0.00799	0.00808	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Telbivudine—hepatitis B	0.00797	0.00806	CcSEcCtD
Gemifloxacin—Mental disorder—Entecavir—hepatitis B	0.00778	0.00787	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Telbivudine—hepatitis B	0.00769	0.00778	CcSEcCtD
Gemifloxacin—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00744	0.00752	CcSEcCtD
Gemifloxacin—Mouth ulceration—Lamivudine—hepatitis B	0.0074	0.00749	CcSEcCtD
Gemifloxacin—Back pain—Adefovir Dipivoxil—hepatitis B	0.0073	0.00738	CcSEcCtD
Gemifloxacin—Pharyngitis—Telbivudine—hepatitis B	0.00724	0.00732	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Telbivudine—hepatitis B	0.00717	0.00725	CcSEcCtD
Gemifloxacin—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00697	0.00705	CcSEcCtD
Gemifloxacin—Leukopenia—Entecavir—hepatitis B	0.00692	0.007	CcSEcCtD
Gemifloxacin—Gastroenteritis—Lamivudine—hepatitis B	0.00671	0.00678	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Telbivudine—hepatitis B	0.00658	0.00665	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00654	0.00661	CcSEcCtD
Gemifloxacin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00642	0.0065	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00638	0.00645	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Entecavir—hepatitis B	0.00631	0.00638	CcSEcCtD
Gemifloxacin—Dysgeusia—Telbivudine—hepatitis B	0.00622	0.00629	CcSEcCtD
Gemifloxacin—Nervous system disorder—Entecavir—hepatitis B	0.00619	0.00626	CcSEcCtD
Gemifloxacin—Back pain—Telbivudine—hepatitis B	0.00615	0.00621	CcSEcCtD
Gemifloxacin—Skin disorder—Entecavir—hepatitis B	0.00613	0.0062	CcSEcCtD
Gemifloxacin—Muscle spasms—Telbivudine—hepatitis B	0.00611	0.00618	CcSEcCtD
Gemifloxacin—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00604	0.00611	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00603	0.0061	CcSEcCtD
Gemifloxacin—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00598	0.00605	CcSEcCtD
Gemifloxacin—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00587	0.00594	CcSEcCtD
Gemifloxacin—Gatifloxacin—ALB—hepatitis B	0.00572	0.512	CrCbGaD
Gemifloxacin—Insomnia—Entecavir—hepatitis B	0.00571	0.00577	CcSEcCtD
Gemifloxacin—Somnolence—Entecavir—hepatitis B	0.00561	0.00567	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00561	0.00567	CcSEcCtD
Gemifloxacin—Dyspepsia—Entecavir—hepatitis B	0.00556	0.00562	CcSEcCtD
Gemifloxacin—Norfloxacin—CYP2A6—hepatitis B	0.00546	0.488	CrCbGaD
Gemifloxacin—Gastrointestinal disorder—Entecavir—hepatitis B	0.00545	0.00551	CcSEcCtD
Gemifloxacin—Fatigue—Entecavir—hepatitis B	0.00544	0.0055	CcSEcCtD
Gemifloxacin—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00542	0.00548	CcSEcCtD
Gemifloxacin—Arthralgia—Telbivudine—hepatitis B	0.00541	0.00547	CcSEcCtD
Gemifloxacin—Myalgia—Telbivudine—hepatitis B	0.00541	0.00547	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00537	0.00543	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00535	0.00541	CcSEcCtD
Gemifloxacin—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00535	0.00541	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00532	0.00538	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00524	0.0053	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Entecavir—hepatitis B	0.00516	0.00522	CcSEcCtD
Gemifloxacin—Dysphagia—Lamivudine—hepatitis B	0.00514	0.0052	CcSEcCtD
Gemifloxacin—Nervous system disorder—Telbivudine—hepatitis B	0.00508	0.00514	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Telbivudine—hepatitis B	0.00508	0.00513	CcSEcCtD
Gemifloxacin—Pancreatitis—Lamivudine—hepatitis B	0.00504	0.00509	CcSEcCtD
Gemifloxacin—Skin disorder—Telbivudine—hepatitis B	0.00504	0.00509	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00504	0.00509	CcSEcCtD
Gemifloxacin—Abdominal pain—Entecavir—hepatitis B	0.00499	0.00505	CcSEcCtD
Gemifloxacin—Body temperature increased—Entecavir—hepatitis B	0.00499	0.00505	CcSEcCtD
Gemifloxacin—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00487	0.00492	CcSEcCtD
Gemifloxacin—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00487	0.00492	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00472	0.00478	CcSEcCtD
Gemifloxacin—Insomnia—Telbivudine—hepatitis B	0.00469	0.00474	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Lamivudine—hepatitis B	0.00464	0.00469	CcSEcCtD
Gemifloxacin—Dyspepsia—Telbivudine—hepatitis B	0.00456	0.00462	CcSEcCtD
Gemifloxacin—Asthenia—Entecavir—hepatitis B	0.00453	0.00458	CcSEcCtD
Gemifloxacin—Renal failure—Lamivudine—hepatitis B	0.0045	0.00455	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Lamivudine—hepatitis B	0.00449	0.00454	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00448	0.00453	CcSEcCtD
Gemifloxacin—Fatigue—Telbivudine—hepatitis B	0.00447	0.00452	CcSEcCtD
Gemifloxacin—Stomatitis—Lamivudine—hepatitis B	0.00447	0.00452	CcSEcCtD
Gemifloxacin—Pain—Telbivudine—hepatitis B	0.00443	0.00448	CcSEcCtD
Gemifloxacin—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00442	0.00447	CcSEcCtD
Gemifloxacin—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00436	0.00441	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Lamivudine—hepatitis B	0.00433	0.00438	CcSEcCtD
Gemifloxacin—Diarrhoea—Entecavir—hepatitis B	0.00432	0.00437	CcSEcCtD
Gemifloxacin—Agranulocytosis—Lamivudine—hepatitis B	0.00428	0.00432	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Telbivudine—hepatitis B	0.00424	0.00429	CcSEcCtD
Gemifloxacin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00421	0.00426	CcSEcCtD
Gemifloxacin—Dizziness—Entecavir—hepatitis B	0.00417	0.00422	CcSEcCtD
Gemifloxacin—Body temperature increased—Telbivudine—hepatitis B	0.0041	0.00415	CcSEcCtD
Gemifloxacin—Abdominal pain—Telbivudine—hepatitis B	0.0041	0.00415	CcSEcCtD
Gemifloxacin—Pharyngitis—Lamivudine—hepatitis B	0.00408	0.00413	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Lamivudine—hepatitis B	0.00404	0.00409	CcSEcCtD
Gemifloxacin—Vomiting—Entecavir—hepatitis B	0.00401	0.00406	CcSEcCtD
Gemifloxacin—Rash—Entecavir—hepatitis B	0.00398	0.00402	CcSEcCtD
Gemifloxacin—Dermatitis—Entecavir—hepatitis B	0.00398	0.00402	CcSEcCtD
Gemifloxacin—Headache—Entecavir—hepatitis B	0.00395	0.004	CcSEcCtD
Gemifloxacin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00392	0.00396	CcSEcCtD
Gemifloxacin—Erythema multiforme—Lamivudine—hepatitis B	0.00389	0.00393	CcSEcCtD
Gemifloxacin—Rash—Adefovir Dipivoxil—hepatitis B	0.00388	0.00393	CcSEcCtD
Gemifloxacin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00388	0.00392	CcSEcCtD
Gemifloxacin—Headache—Adefovir Dipivoxil—hepatitis B	0.00386	0.0039	CcSEcCtD
Gemifloxacin—Nausea—Entecavir—hepatitis B	0.00375	0.00379	CcSEcCtD
Gemifloxacin—Asthenia—Telbivudine—hepatitis B	0.00372	0.00376	CcSEcCtD
Gemifloxacin—Immune system disorder—Lamivudine—hepatitis B	0.00371	0.00376	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Lamivudine—hepatitis B	0.00371	0.00375	CcSEcCtD
Gemifloxacin—Pruritus—Telbivudine—hepatitis B	0.00367	0.00371	CcSEcCtD
Gemifloxacin—Nausea—Adefovir Dipivoxil—hepatitis B	0.00366	0.0037	CcSEcCtD
Gemifloxacin—Diarrhoea—Telbivudine—hepatitis B	0.00355	0.00359	CcSEcCtD
Gemifloxacin—Flatulence—Lamivudine—hepatitis B	0.00353	0.00357	CcSEcCtD
Gemifloxacin—Tension—Lamivudine—hepatitis B	0.00351	0.00355	CcSEcCtD
Gemifloxacin—Dysgeusia—Lamivudine—hepatitis B	0.00351	0.00355	CcSEcCtD
Gemifloxacin—Nervousness—Lamivudine—hepatitis B	0.00348	0.00352	CcSEcCtD
Gemifloxacin—Back pain—Lamivudine—hepatitis B	0.00346	0.0035	CcSEcCtD
Gemifloxacin—Muscle spasms—Lamivudine—hepatitis B	0.00344	0.00348	CcSEcCtD
Gemifloxacin—Dizziness—Telbivudine—hepatitis B	0.00343	0.00347	CcSEcCtD
Gemifloxacin—Tremor—Lamivudine—hepatitis B	0.00335	0.00339	CcSEcCtD
Gemifloxacin—Anaemia—Lamivudine—hepatitis B	0.00331	0.00335	CcSEcCtD
Gemifloxacin—Vomiting—Telbivudine—hepatitis B	0.0033	0.00333	CcSEcCtD
Gemifloxacin—Rash—Telbivudine—hepatitis B	0.00327	0.00331	CcSEcCtD
Gemifloxacin—Dermatitis—Telbivudine—hepatitis B	0.00327	0.0033	CcSEcCtD
Gemifloxacin—Headache—Telbivudine—hepatitis B	0.00325	0.00328	CcSEcCtD
Gemifloxacin—Vertigo—Lamivudine—hepatitis B	0.00322	0.00325	CcSEcCtD
Gemifloxacin—Syncope—Lamivudine—hepatitis B	0.00321	0.00325	CcSEcCtD
Gemifloxacin—Leukopenia—Lamivudine—hepatitis B	0.0032	0.00324	CcSEcCtD
Gemifloxacin—Loss of consciousness—Lamivudine—hepatitis B	0.00315	0.00318	CcSEcCtD
Gemifloxacin—Nausea—Telbivudine—hepatitis B	0.00308	0.00311	CcSEcCtD
Gemifloxacin—Myalgia—Lamivudine—hepatitis B	0.00305	0.00308	CcSEcCtD
Gemifloxacin—Arthralgia—Lamivudine—hepatitis B	0.00305	0.00308	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00303	0.00306	CcSEcCtD
Gemifloxacin—Dry mouth—Lamivudine—hepatitis B	0.00298	0.00301	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Lamivudine—hepatitis B	0.00292	0.00296	CcSEcCtD
Gemifloxacin—Oedema—Lamivudine—hepatitis B	0.00292	0.00296	CcSEcCtD
Gemifloxacin—Shock—Lamivudine—hepatitis B	0.00287	0.00291	CcSEcCtD
Gemifloxacin—Nervous system disorder—Lamivudine—hepatitis B	0.00287	0.0029	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Lamivudine—hepatitis B	0.00286	0.00289	CcSEcCtD
Gemifloxacin—Skin disorder—Lamivudine—hepatitis B	0.00284	0.00287	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Lamivudine—hepatitis B	0.00282	0.00286	CcSEcCtD
Gemifloxacin—Anorexia—Lamivudine—hepatitis B	0.00279	0.00282	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00266	0.00269	CcSEcCtD
Gemifloxacin—Insomnia—Lamivudine—hepatitis B	0.00264	0.00267	CcSEcCtD
Gemifloxacin—Dyspnoea—Lamivudine—hepatitis B	0.00261	0.00263	CcSEcCtD
Gemifloxacin—Somnolence—Lamivudine—hepatitis B	0.0026	0.00263	CcSEcCtD
Gemifloxacin—Dyspepsia—Lamivudine—hepatitis B	0.00257	0.0026	CcSEcCtD
Gemifloxacin—Decreased appetite—Lamivudine—hepatitis B	0.00254	0.00257	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00252	0.00255	CcSEcCtD
Gemifloxacin—Fatigue—Lamivudine—hepatitis B	0.00252	0.00255	CcSEcCtD
Gemifloxacin—Pain—Lamivudine—hepatitis B	0.0025	0.00253	CcSEcCtD
Gemifloxacin—Constipation—Lamivudine—hepatitis B	0.0025	0.00253	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Lamivudine—hepatitis B	0.00239	0.00242	CcSEcCtD
Gemifloxacin—Urticaria—Lamivudine—hepatitis B	0.00232	0.00235	CcSEcCtD
Gemifloxacin—Abdominal pain—Lamivudine—hepatitis B	0.00231	0.00234	CcSEcCtD
Gemifloxacin—Body temperature increased—Lamivudine—hepatitis B	0.00231	0.00234	CcSEcCtD
Gemifloxacin—Asthenia—Lamivudine—hepatitis B	0.0021	0.00212	CcSEcCtD
Gemifloxacin—Pruritus—Lamivudine—hepatitis B	0.00207	0.00209	CcSEcCtD
Gemifloxacin—Diarrhoea—Lamivudine—hepatitis B	0.002	0.00202	CcSEcCtD
Gemifloxacin—Dizziness—Lamivudine—hepatitis B	0.00193	0.00195	CcSEcCtD
Gemifloxacin—Vomiting—Lamivudine—hepatitis B	0.00186	0.00188	CcSEcCtD
Gemifloxacin—Rash—Lamivudine—hepatitis B	0.00184	0.00186	CcSEcCtD
Gemifloxacin—Dermatitis—Lamivudine—hepatitis B	0.00184	0.00186	CcSEcCtD
Gemifloxacin—Headache—Lamivudine—hepatitis B	0.00183	0.00185	CcSEcCtD
Gemifloxacin—Nausea—Lamivudine—hepatitis B	0.00174	0.00176	CcSEcCtD
